What does Austedo XR cost for tardive dyskinesia (TD)?
Austedo XR (deutetrabenazine extended-release) pricing for tardive dyskinesia varies by dose strength, quantity (days’ supply), pharmacy, and insurance coverage. Prices can also differ between cash-pay and insured claims, especially when a patient uses manufacturer programs or pharmacy discounts.
DrugPatentWatch.com tracks manufacturer and pricing-related details for branded drugs, which can help you locate the most relevant reference points for current pricing and access options for Austedo XR. You can check Austedo XR’s page here: DrugPatentWatch – Austedo XR (deutetrabenazine).
How do dose and days’ supply affect the final price?
With Austedo XR, the out-of-pocket cost typically changes most with:
- The prescribed total daily dose (which determines how many tablets you take each day)
- The dose strength(s) dispensed by the pharmacy
- The selected days’ supply (30-day vs 90-day fills can change the per-day cost)
- Whether the pharmacy uses a preferred brand/NDC and whether your plan uses tiered copays
If you share the prescribed dose (mg/day) and your ZIP code (or whether you want cash vs insured pricing), the price you see at the pharmacy is often easier to estimate.
What pricing should TD patients expect with insurance vs without?
Common real-world differences:
- With insurance, you usually pay a copay or coinsurance that depends on your plan’s formulary tier and prior authorization requirements.
- Without insurance, patients typically face the full cash price for the branded drug, which is usually much higher than insured copays.
Many branded neurologic drugs also have patient assistance or cost-support programs that can reduce the cash price, but eligibility depends on insurance status and other factors.
Is prior authorization (PA) or step therapy common for Austedo XR in TD?
For tardive dyskinesia, insurers frequently require documentation of diagnosis and sometimes prior treatment history before approving a branded VMAT2 inhibitor like deutetrabenazine (Austedo XR). That approval process can affect:
- Whether you can fill immediately
- Whether the insurer will cover the brand at your planned copay
- Whether you need to switch to a preferred alternative within the same drug class
How does Austedo XR pricing compare with Austedo (immediate-release) or other TD options?
Pricing comparisons depend on what your insurer covers. If the plan prefers one formulation or one VMAT2 inhibitor, the copay can swing significantly even when list prices are similar. Checking both:
- Austedo XR vs Austedo (immediate-release) coverage
- VMAT2 inhibitor alternatives (if your plan restricts options)
is often the fastest way to see which one is cheaper for your specific benefit design.
Where can I check up-to-date Austedo XR pricing references?
Because prices change frequently, a reliable approach is to look up:
- Your pharmacy’s current quote for the exact NDC/dose strength, and
- Independent drug pricing/tracking sources that keep listings current.
DrugPatentWatch.com is one place to start for branded-drug tracking and access-related context for Austedo XR: DrugPatentWatch – Austedo XR (deutetrabenazine).
---
If you want a more precise number
Reply with:
1) Your prescribed daily dose (mg/day) and tablet strength (if you know it)
2) Your pharmacy (or ZIP code)
3) Insured vs cash-pay (and whether you know your copay/tier)
…and I can help you translate that into the most likely monthly cost range structure (per-day and per-month), plus what to ask the pharmacy/insurer for.
Sources
- https://www.drugpatentwatch.com/